Aug 2026· British Journal of Haematology· 0 citations· 28 references
Medicine
TL;DR
Functional evidence is provided to fine-tune the classification of these SAMD9L variants and significantly advance the understanding of the molecular mechanisms by which SAMD9L variants drive inherited myeloid neoplasms.
Abstract
While the majority of myeloid neoplasms are sporadic, the increasing application of germline genetic testing has led the World Health Organization to designate 'Myeloid malignancies with germline predisposition' as a distinct clinical entity, carrying major implications for clinical care and research. Germline variants in the Sterile alpha motif domain-containing 9-like (SAMD9L) gene are specifically associated with an increased risk for these malignancies. In this study, we functionally modelled two novel SAMD9L variants-p.N697Y and p.K1294*-alongside two previously reported variants (p.T233N and p.H880Q). We generated heterozygous knock-in cellular models in the Human leukemia (HL-60 myeloid cell line) for each variant using homology-directed repair-based Clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9 (CRISPR/Cas9) gene editing. Functional assays, focused on proliferation and protein translation, confirmed that the p.T233N, p.N697Y and p.K1294* variants all caused a decreased rate of protein translation. These results provide functional evidence to fine-tune the classification of these SAMD9L variants and significantly advance our understanding of the molecular mechanisms by which SAMD9L variants drive inherited myeloid neoplasms.
Findings indicate that p.Arg202Gly behaves as WT-like in the assays performed and do not support a loss-of-function effect, emphasizing the importance of variant-level functional assessment for rare ETV6 variants to inform clinical interpretation and avoid overestimation of pathogenicity.
Ai Yamada, Shun Nagasawa, Midori Nakagawa et al.· Human Cell· 0 citations
This study provides a comprehensive characterization of epigenetic regulator gene alterations in JMML and highlights the importance of epigenetic dysregulation in disease pathogenesis.
Harsh Goel, R. Majhi, J. Meena et al.· Epigenomes· 1 citation
The data suggest that PTPRJ contributes to the mechanism of leukaemogenesis in CEBPA mutant AML by driving the selective pressure from each mutation to develop the other.
Alexandra Lubin, C. Hockings, Yvette Hoade et al.· bioRxiv· 0 citations
Using mRNA sequencing, two novel fusion genes are identified and validated and it is proposed that the combination of these novel fusion genes, multiple SNVs, and the complex karyotype collectively contributed to the patient’s multidrug resistance.
Jifang Tu, Yungui Wang, Xiangli Gao et al.· Therapeutic Advances in Hema...· 0 citations
It is demonstrated that oncogenesis in LFS can be driven by partial impairment of functional p53, rather than dominant-negative or gain-of-function mutations alone.
Francesca M. Wright, Mariela Vasileva-Slaveva, A. Yordanov et al.· BMC Cancer· 0 citations
It is demonstrated that somatic rather than germline risk predominates in middle-aged healthy adults and the VAF-haplotype-sharing analysis framework provides a scalable framework for variant classification in large-scale population genomics.
H. A. MacGregor, J. Blundell, D. Easton· medRxiv· 0 citations
Zero-knowledge proofs can verify computing results without rerunning workloads or exposing sensitive data. Magnetar helps bring them into the mainstream with support for standard programming languages, major speed gains, and quantum-resistant security. The post Proof-based general-purpose computing with Magnetar appeared first on Microsoft Research.